ACARBOSE TREATMENT OF SULFONYLUREA-TREATED NON-INSULIN DEPENDENT DIABETICS - A DOUBLE-BLIND CROSSOVER COMPARISON OF AN ALPHA-GLYCOSIDASE INHIBITOR WITH METFORMIN

被引：0
|
作者：
JOHANSEN, K
机构：
来源：
DIABETES & METABOLISM | 1984年 / 10卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：219 / 223
页数：5
相关论文
共 9 条
  • [1] ACARBOSE TREATMENT IN INSULIN-DEPENDENT DIABETICS - A DOUBLE-BLIND CROSSOVER STUDY
    VIVIANI, GL
    CAMOGLIANO, L
    BORGOGLIO, MG
    SALVINI, P
    OHNMEISS, H
    ADEZATI, L
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1987, 42 (01): : 1 - 11
  • [2] LONG-TERM TREATMENT OF SULFONYLUREA-TREATED DIABETICS WITH THE ALPHA-GLUCOSIDASE INHIBITOR BAY G 5421 (ACARBOSE)
    VIERHAPPER, H
    BRATUSCHMARRAIN, P
    WALDHAUSL, W
    DIABETOLOGIA, 1981, 20 (05) : 586 - 586
  • [3] COMPARISON OF ACARBOSE AND PHENFORMIN TREATMENT IN GLIBENCLAMIDE-TREATED NON-INSULIN-DEPENDENT DIABETICS
    PAGANO, G
    CASSADER, M
    CAVALLOPERIN, P
    DALMOLIN, V
    CARTA, Q
    FASANI, R
    SALVINI, P
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1986, 39 (01): : 143 - 148
  • [4] TREATING HYPERTENSION IN BLACK COMPARED WITH WHITE NON-INSULIN DEPENDENT DIABETICS - A DOUBLE-BLIND TRIAL OF VERAPAMIL AND METOPROLOL
    CRUICKSHANK, JK
    ANDERSON, NM
    WADSWORTH, J
    YOUNG, SM
    JEPSON, E
    BRITISH MEDICAL JOURNAL, 1988, 297 (6657): : 1155 - 1159
  • [5] REDUCED GLYCOSURIA DURING GUAR GUM SUPPLEMENTATION IN NON-INSULIN-DEPENDENT DIABETICS - A DOUBLE-BLIND, RANDOMIZED CROSSOVER STUDY
    STOKHOLM, KH
    LAURITSEN, KB
    LARSEN, S
    DANISH MEDICAL BULLETIN, 1981, 28 (01): : 41 - 42
  • [6] INSULIN-RECEPTOR BINDING TO MONOCYTES, INSULIN-SECRETION, AND GLUCOSE-TOLERANCE FOLLOWING METFORMIN TREATMENT - RESULTS OF A DOUBLE-BLIND CROSSOVER STUDY IN TYPE-II DIABETICS
    PRAGER, R
    SCHERNTHANER, G
    DIABETES, 1983, 32 (12) : 1083 - 1086
  • [7] Influence of 16-week monotherapy with acarbose on cardiovascular risk factors in obese subjects with non-insulin-dependent diabetes mellitus: A controlled, double-blind comparison study with placebo
    CallePascual, A
    GarciaHonduvilla, J
    MartinAlvarez, PJ
    Calle, JR
    Maranes, JP
    DIABETES & METABOLISM, 1996, 22 (03): : 201 - 202
  • [8] MIGLITOL AS AN ADDITIVE TO GLIBENCLAMIDE AND CHLORPROPAMIDE IN THE TREATMENT OF TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS DURING A 12-WEEK PERIOD - DOUBLE-BLIND COMPARISON WITH PLACEBO
    MILICIC, I
    PROFOZIC, V
    GRANIC, M
    SCHULTZ, H
    HILLEBRANDT, I
    SKRABALO, Z
    DIABETOLOGIA, 1987, 30 (07) : A558 - A558
  • [9] TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea-a MASTERMIND study protocol
    Angwin, Catherine
    Jenkinson, Caroline
    Jones, Angus
    Jennison, Christopher
    Henley, William
    Farmer, Andrew
    Sattar, Naveed
    Holman, Rury R.
    Pearson, Ewan
    Shields, Beverley
    Hattersley, Andrew
    BMJ OPEN, 2020, 10 (12):
1